September 2017

Chairman's Letter
Chairman’s Letter
Michael J. Hennessy, Sr
From The Editor
From the Editor
Debu Tripathy, MD
Colorectal Cancer
Targeted Therapy and the Use of Molecular Profiling in Metastatic Colorectal Cancer
Gagandeep Brar, MD; John L. Marshall, MD; and Michael J. Pishvaian, MD, PhD
Hodgkin Lymphoma
Reshaping the Field of Hodgkin Lymphoma
Lori A. Leslie, MD; Andre H. Goy, MD, MS; and Tatyana A. Feldman, MD
Lung Cancer
Case Report: Detection of c797s as a Mechanism of Resistance in a Patient With Lung Cancer With EGFR Mutations
Luis E. Raez, MD, and Christian Rolfo, MD, PhD, MBA
Polycythemia Vera
Polycythemia Vera: Contemporary Updates in Diagnosis, Prognosis, and Treatment
Saba S. Shaikh, MD, and Brady L. Stein, MD, MHS
The Evolution of Frontline Therapy in ALK-Positive Advanced NSCLC: Which ALK TKI to Use Upfront?
Current and Emerging Role of PARP Inhibitors in Breast Cancer
Angela DeMichele, MD, MSCE